Not applicableStudy completedNCT02477254What this trial is testingLong-term Immunogenicity of a HPV Vaccine in SLEWho this might be right forSystemic Lupus Erythematosus Tuen Mun Hospital 84
Not applicableLooking for participantsNCT07301905What this trial is testingCulturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MIWho this might be right forHPV Vaccination Michigan State University 265
Not applicableEnded earlyNCT06367699What this trial is testingConversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical TrialWho this might be right forHuman Papilloma Virus Tufts Medical Center 29
Not applicableUnknownNCT00666107What this trial is testingPilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected MenWho this might be right forAnal CancerHIV Infections Southern California Institute for Research and Education 150
Not applicableStudy completedNCT03497936What this trial is testingMarketability of a Technology-based Intervention to Increase HPV VaccinationWho this might be right forHuman Papilloma Virus Real Prevention, LLC 360
Not applicableStudy completedNCT03824093What this trial is testingHigh and Low Resource Interventions to Promote HPV VaccinesWho this might be right forHuman Papilloma VirusTdap - Tetanus, Diphtheria and Acellular Pertussis VaccinationMeningitis, Meningococcal+2 more Children's Mercy Hospital Kansas City 225
Not applicableActive Not RecruitingNCT05744960What this trial is testingImpact of Financial IncentivesWho this might be right forHuman Papilloma Virus UNC Lineberger Comprehensive Cancer Center 34
Large-scale testing (Phase 3)Study completedNCT00316706What this trial is testingHuman Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 VaccineWho this might be right forCervical Intraepithelial NeoplasiaPapillomavirus Infection GlaxoSmithKline 1,245
Not applicableUnknownNCT01314404What this trial is testingKAP/WTP and HPV Prevalence Studies in a Developing World Setting (Bamako, Mali)Who this might be right forHuman Papillomavirus Global Alliance to Immunize Against AIDS Vaccine Foundation 460
Not applicableUnknownNCT05658198What this trial is testingInvestigating HPV Vaccination Uptake in Adults Aged 18-35 Seeking Care at a Health Clinic in Rural MississippiWho this might be right forHuman Papillomavirus Vaccination Plan A Health, Inc 100
Testing effectiveness (Phase 2)Study completedNCT04432597What this trial is testingHPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated CancersWho this might be right forHPV Positive CancerVulvar, Vaginal, Penile, Rectal CancerAnal Cancer+2 more National Cancer Institute (NCI) 39
Not applicableUnknownNCT04671823What this trial is testingChanges in the Prevalence of Oncogenic HPV TypesWho this might be right forPapillomavirus VaccinesPapillomavirus Infections Kanazawa Medical University 1,500
Testing effectiveness (Phase 2)Looking for participantsNCT07407569What this trial is testingDeveloping a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After HPV VaccinationWho this might be right forHuman Papilloma Virus Infection Type 16 Universiteit Antwerpen 50
Not applicableStudy completedNCT03294551What this trial is testingHPV Centralized R/R RCT #2 - New York StateWho this might be right forVaccines University of California, Los Angeles 37,003
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06681636What this trial is testingEffector and Memory Immune Responses to HPV Vaccination in Vietnamese Women Post Virus ExposureWho this might be right forHPV InfectionCervical CancerAnogenital Cancer+1 more National Institute of Hygiene and Epidemiology, Vietnam 300
Large-scale testing (Phase 3)Study completedNCT00481767What this trial is testingImmunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age.Who this might be right forHuman Papillomavirus (HPV) Infection GlaxoSmithKline 676
Not applicableStudy completedNCT03438006What this trial is testingA Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese SubjectsWho this might be right forCervical Intraepithelial Neoplasia GlaxoSmithKline 3,016
Large-scale testing (Phase 3)Study completedNCT00456807What this trial is testingComplementary Testing to Evaluate Immunogenicity of Human Papillomavirus (HPV) Vaccine (580299) in Healthy Female Subjects Aged >/= 26 YearsWho this might be right forInfections, Papillomavirus GlaxoSmithKline 100
Not applicableStudy completedNCT02551887What this trial is testingHPV Vaccination: An Investigation of Physician Reminders and Recommendation ScriptsWho this might be right forHuman Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more Regenstrief Institute, Inc. 647
Not applicableStudy completedNCT07521163What this trial is testingEffect of Health Belief Model-Based Education on Cervical Cancer Knowledge and HPV Vaccine Attitudes in WomenWho this might be right forCervical CancerHuman Papillomavirus InfectionPreventive Health Services Muhammet Faruk Yigit 154